Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit

Hannover Medical School64 enrolled

Overview

The prospective, randomized, two centre study investigates acute cerebrovascular events during extracorporal circulation and the early post operative outcome when using either the minimized cardiopulmonary bypass circuit (ROCsafeTM) or a standard cardiopulmonary bypass circuit in patients undergoing coronary artery bypass grafting.

Coronary artery bypass grafting with extracorporal circulation is established as the golden standard. The conventional cardiopulmonary bypass (CPB) system is associated with inflammatory reaction, hemolysis, hemodilution an disturbances of the blood coagulation system. Also it's well known that neurological disturbances caused by embolic material and air bubbles are potential risks of CPB. The new minimized perfusion circuit ROCsafeTM is a closed, reservoir-less, reduced prime, surface coated circuit, with optimized safety features in effectively eliminate both macro and micro air bubbles and should optimize the clinical outcome after CABG using cardiopulmonary bypass.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Coronary Artery Disease Acute Cerebrovascular Accident Intracranial Embolism Embolism, Air

Interventions

ROCsafeTMDEVICE

using minimized perfusion circuit while CABG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient is older than 17 years * Patient is acceptable candidate for CABG operation * Patient or the patient's legal representative has been informed of the nature of the study and agrees to its provisions and has provided written informed consent. Exclusion Criteria: * Ejection fraction less than 30 % * Valve surgery * Acute endocarditis or history of endocarditis * Cerebral ischemia within 4 weeks before surgery * Detection of intracardial thrombi in preoperative echocardiography * Stenosis of A. carotis int. greater than 70 % * Patients older than 80 years * Patients on dialysis * Acute myocardial ischemia or infarction within two weeks before inclusion * Markedly elevated baseline C-reactive protein (CRP) or leucocytosis * Cancer or immunologic diseases * Dysregulation of the coagulation cascade (not concerning INR or PTT under cumarin or heparin treatment) * Intake of steroids or NSAR * Female of childbearing potential * Participation in an other study * Contraindication for MRI (e.g. pacemaker, any kind of implanted metal) * Claustrophobia

Locations (2)

Klinikum Braunschweig, Department of Cardiothoracic Surgery

Braunschweig, Germany

RECRUITING

Hannover Medical School, Clinic for Cardiac, Thoracic, Transplantation and Vascular Surgery

Hanover, Germany

RECRUITING

Outcomes

Primary Outcomes

fresh micro-lesions in cranial MRT

Time frame: before and 72 h after CABG

Secondary Outcomes

Death

Time frame: 30 days after CABG

Neurological events

Time frame: between CABG and discharge

Neurocognitive function

Time frame: before and 3-4 days after CABG and after 3 months

Central Contacts

Ingo Kutschka, PD Dr. med.

CONTACT

0049-511-532-2154 kutschka.ingo@mh-hannover.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.